Teleflex Incorporated (NYSE:TFX) Shares Bought by Speece Thorson Capital Group Inc.

Speece Thorson Capital Group Inc. boosted its stake in shares of Teleflex Incorporated (NYSE:TFX - Free Report) by 20.6% in the first quarter, according to its most recent disclosure with the SEC. The firm owned 87,747 shares of the medical technology company's stock after acquiring an additional 14,969 shares during the period. Teleflex comprises about 2.5% of Speece Thorson Capital Group Inc.'s holdings, making the stock its 21st biggest holding. Speece Thorson Capital Group Inc. owned 0.19% of Teleflex worth $12,126,000 as of its most recent filing with the SEC.

A number of other large investors also recently added to or reduced their stakes in TFX. MassMutual Private Wealth & Trust FSB raised its position in Teleflex by 103.1% during the first quarter. MassMutual Private Wealth & Trust FSB now owns 197 shares of the medical technology company's stock worth $27,000 after acquiring an additional 100 shares during the period. Headlands Technologies LLC acquired a new position in Teleflex during the fourth quarter worth $29,000. Whipplewood Advisors LLC raised its position in Teleflex by 7,700.0% during the first quarter. Whipplewood Advisors LLC now owns 234 shares of the medical technology company's stock worth $32,000 after acquiring an additional 231 shares during the period. Allworth Financial LP raised its position in Teleflex by 504.8% during the first quarter. Allworth Financial LP now owns 254 shares of the medical technology company's stock worth $34,000 after acquiring an additional 212 shares during the period. Finally, True Wealth Design LLC raised its position in Teleflex by 62.3% during the fourth quarter. True Wealth Design LLC now owns 271 shares of the medical technology company's stock worth $48,000 after acquiring an additional 104 shares during the period. 95.62% of the stock is currently owned by institutional investors and hedge funds.

Teleflex Trading Down 2.9%

Shares of TFX opened at $116.46 on Friday. The company has a current ratio of 2.28, a quick ratio of 1.32 and a debt-to-equity ratio of 0.44. Teleflex Incorporated has a 12-month low of $115.94 and a 12-month high of $249.91. The firm has a 50-day moving average price of $121.71 and a 200 day moving average price of $143.52. The firm has a market capitalization of $5.15 billion, a P/E ratio of 36.74, a P/E/G ratio of 1.82 and a beta of 1.08.

Teleflex (NYSE:TFX - Get Free Report) last announced its quarterly earnings data on Thursday, May 1st. The medical technology company reported $2.91 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.88 by $0.03. Teleflex had a net margin of 4.96% and a return on equity of 14.73%. The firm had revenue of $700.67 million during the quarter, compared to analyst estimates of $699.37 million. During the same quarter in the prior year, the firm posted $3.21 earnings per share. Teleflex's quarterly revenue was down 5.0% on a year-over-year basis. Sell-side analysts forecast that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, June 16th. Investors of record on Tuesday, May 20th were issued a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.17%. The ex-dividend date was Tuesday, May 20th. Teleflex's dividend payout ratio is currently 42.90%.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on TFX shares. Morgan Stanley reduced their price objective on shares of Teleflex from $191.00 to $173.00 and set an "overweight" rating for the company in a research report on Monday, May 5th. Mizuho set a $155.00 target price on shares of Teleflex in a report on Wednesday, April 16th. Royal Bank Of Canada dropped their target price on shares of Teleflex from $150.00 to $145.00 and set a "sector perform" rating for the company in a report on Friday, May 2nd. Wall Street Zen lowered shares of Teleflex from a "buy" rating to a "hold" rating in a report on Sunday, June 29th. Finally, Wells Fargo & Company dropped their target price on shares of Teleflex from $146.00 to $137.00 and set an "equal weight" rating for the company in a report on Friday, May 2nd. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat.com, Teleflex has a consensus rating of "Hold" and a consensus target price of $164.63.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.